International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort studyWolfgang R. Sperr, Peter Valent, Karoline V. Gleixner et al.|The Lancet Haematology|2019Cited by 140
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classificationJakub Trizuljak, Wolfgang R. Sperr, Lucie Nekvindová et al.|Allergy|2020Cited by 77
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM RegistryHanneke C. Kluin‐Nelemans, Wolfgang R. Sperr, Andreas Reiter et al.|Leukemia|2019Cited by 55
Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the SkinDavid Fuchs, Peter Valent, Alex Kilbertus et al.|The Journal of Allergy and Clinical Immunology In Practice|2020Cited by 31